Companies collaborate on clinical stage nuclear medicine therapy for neuroendocrine tumors ST. LOUIS -- Oct. 15, 2007--Covidien and BioSynthema Inc. today announced the signing of agreements to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results